[Elsevier] Comparative effectiveness of first-line targeted therapies in ALK-positive non-small cell lung cancer: real-world evidence of tyrosine kinase inhibitors |
|
This post will be closed automatically in 2026-10-27 05:03
Best Answer
6 day(s) ago
|
| |
100
Multiscale modeling of catalyst deactivation in dry methane reforming
100
Particle size distribution degradation model for PEM fuel cell Pt/C catalyst based on population balance equation
10
Toward a formal sociological model of partner search
20
RIFM fragrance ingredient safety assessment, eucalyptol, CAS Registry Number 470-82-6
10
Multi-strategy enhanced snake optimizer for quantitative structure-activity relationship modeling
